EP Patent

EP3693044A1 — Breath actuated inhalers

Assigned to Koninklijke Philips NV · Expires 2020-08-12 · 6y expired

What this patent protects

An accessory (50, 80) is for application to the air inlet of a breath actuated inhaler (10). It has an assist chamber for holding a volume of air and a mechanical release system for expelling air from the assist chamber to the air inlet (19), at a rate sufficient to trigger a dos…

USPTO Abstract

An accessory (50, 80) is for application to the air inlet of a breath actuated inhaler (10). It has an assist chamber for holding a volume of air and a mechanical release system for expelling air from the assist chamber to the air inlet (19), at a rate sufficient to trigger a dose trigger mechanism (30) of the breath actuated inhaler. In this way, a user may use a breath actuated inhaler even if they do not have the ability to generate an inhalation suitable for activating the inhaler.

Drugs covered by this patent

Patent Metadata

Patent number
EP3693044A1
Jurisdiction
EP
Classification
—
Expires
2020-08-12
Drug substance claim
No
Drug product claim
No
Assignee
Koninklijke Philips NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.